Teladoc Checks Up Great
In our busy lives, very few people have time to wait in a doctor's office for a routine check up. Teladoc provides a much more convenient solution. Why note just have a virtual visit with a doctor instead? Even once COVID-19 is over, I think people will prefer to see a doctor this way. First, it allows them to avoid traveling and waiting in a doctor's office. Second, it enables patients to see a doctor who they really like that may not practice in a location close to them. From a doctor's point of view, it allows them to choose a more affordable location for their office and to potentially see more patients since the visit is done remotely.
The chart of Teladoc Health ($TDOC) is also very constructive. TDOC went on a monster run in the Spring of 2020 as COVID-19 ripped across the globe. During the past seven months or so, it has been moving quietly sideways after acquiring Livongo Health.
What really appeals to me about TDOC is two things. First, it is building an extremely large base on the weekly chart. A base of this length can lead to an explosive multi-month move higher. In addition, Teladoc has a service that can change the lives of almost everyone. Companies that offer revolutionary products that can drastically improve the lives of millions of people offer the potential for enormous gains. Think Tesla and Zoom in 2020.
I took a position in Teladoc today. I will look to add to my position if further buy points emerge and my initial buy continues to show me a profit.
To learn more about trading, visit my course page.
Full Disclosure: Teladoc is a stock I currently own.
Disclaimer: This information is issued solely for informational and educational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. None of the information contained in this post constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. From time to time, the content creator or its affiliates may hold positions or other interests in securities mentioned in this blog or the associated Twitter and Instagram feeds. The stock or stocks presented are not to be considered a recommendation to buy any stock or stocks. This material does not take into account your particular investment objectives. Investors should consult their own financial or investment adviser before trading or acting upon any information provided. Past performance is not indicative of future results.